These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 30037010)
1. Bioengineering of Chenal A; Ladant D Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30037010 [TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis. Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322 [TBL] [Abstract][Full Text] [Related]
3. Bioengineering of Ladant D Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260 [TBL] [Abstract][Full Text] [Related]
4. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells. Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520 [TBL] [Abstract][Full Text] [Related]
5. Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin. Espinosa-Vinals CA; Masin J; Holubova J; Stanek O; Jurnecka D; Osicka R; Sebo P; Bumba L J Biol Chem; 2021 Jul; 297(1):100833. PubMed ID: 34051233 [TBL] [Abstract][Full Text] [Related]
6. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). Guermonprez P; Khelef N; Blouin E; Rieu P; Ricciardi-Castagnoli P; Guiso N; Ladant D; Leclerc C J Exp Med; 2001 May; 193(9):1035-44. PubMed ID: 11342588 [TBL] [Abstract][Full Text] [Related]
7. Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of Holubova J; Juhasz A; Masin J; Stanek O; Jurnecka D; Osickova A; Sebo P; Osicka R Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769101 [TBL] [Abstract][Full Text] [Related]
8. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells. Simsova M; Sebo P; Leclerc C Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033 [TBL] [Abstract][Full Text] [Related]
10. Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin. Angely C; Ladant D; Planus E; Louis B; Filoche M; Chenal A; Isabey D PLoS One; 2020; 15(5):e0228606. PubMed ID: 32392246 [TBL] [Abstract][Full Text] [Related]
11. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151 [TBL] [Abstract][Full Text] [Related]
12. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005 [TBL] [Abstract][Full Text] [Related]
13. Identification of a region that assists membrane insertion and translocation of the catalytic domain of Bordetella pertussis CyaA toxin. Karst JC; Barker R; Devi U; Swann MJ; Davi M; Roser SJ; Ladant D; Chenal A J Biol Chem; 2012 Mar; 287(12):9200-12. PubMed ID: 22241477 [TBL] [Abstract][Full Text] [Related]
14. Membrane Activity and Channel Formation of the Adenylate Cyclase Toxin (CyaA) of Knapp O; Benz R Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164365 [TBL] [Abstract][Full Text] [Related]
15. Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme. Masin J; Osicka R; Bumba L; Sebo P Pathog Dis; 2015 Nov; 73(8):ftv075. PubMed ID: 26391732 [TBL] [Abstract][Full Text] [Related]
16. Ahmad JN; Holubova J; Benada O; Kofronova O; Stehlik L; Vasakova M; Sebo P mBio; 2019 Sep; 10(5):. PubMed ID: 31551332 [TBL] [Abstract][Full Text] [Related]
17. Exposure to Bordetella pertussis adenylate cyclase toxin affects integrin-mediated adhesion and mechanics in alveolar epithelial cells. Angely C; Nguyen NM; Andre Dias S; Planus E; Pelle G; Louis B; Filoche M; Chenal A; Ladant D; Isabey D Biol Cell; 2017 Aug; 109(8):293-311. PubMed ID: 28597954 [TBL] [Abstract][Full Text] [Related]
18. Transmembrane segments of complement receptor 3 do not participate in cytotoxic activities but determine receptor structure required for action of Bordetella adenylate cyclase toxin. Wald T; Osickova A; Masin J; Liskova PM; Petry-Podgorska I; Matousek T; Sebo P; Osicka R Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26802078 [TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins. Gmira S; Karimova G; Ladant D Res Microbiol; 2001 Dec; 152(10):889-900. PubMed ID: 11766964 [TBL] [Abstract][Full Text] [Related]
20. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain. El-Azami-El-Idrissi M; Bauche C; Loucka J; Osicka R; Sebo P; Ladant D; Leclerc C J Biol Chem; 2003 Oct; 278(40):38514-21. PubMed ID: 12885782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]